# Treatment Patterns and Outcomes Study in Patients With Unresectable Stage III and Metastatic (Stage IV) Melanoma in the United States

> **NCT03199846** · — · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 650 (actual)

## Conditions studied

- Melanoma

## Interventions

- **OTHER:** Non-Interventional

## Key facts

- **NCT ID:** NCT03199846
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10-25
- **Primary completion:** 2017-10-30
- **Final completion:** 2017-12-31
- **Target enrollment:** 650 (ACTUAL)
- **Last updated:** 2018-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03199846

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03199846, "Treatment Patterns and Outcomes Study in Patients With Unresectable Stage III and Metastatic (Stage IV) Melanoma in the United States". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT03199846. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*